Multiparametric MRI of prostate cancer: An update on state‐of‐the‐art techniques and their performance in detecting and localizing prostate cancer

Magnetic resonance (MR) examinations of men with prostate cancer are most commonly performed for detecting, characterizing, and staging the extent of disease to best determine diagnostic or treatment strategies, which range from biopsy guidance to active surveillance to radical prostatectomy. Given both the exam's importance to individual treatment plans and the time constraints present for its operation at most institutions, it is essential to perform the study effectively and efficiently. This article reviews the most commonly employed modern techniques for prostate cancer MR examinations, exploring the relevant signal characteristics from the different methods discussed and relating them to intrinsic prostate tissue properties. Also, a review of recent articles using these methods to enhance clinical interpretation and assess clinical performance is provided. J. Magn. Reson. Imaging 2013;37:1035–1054. © 2013 Wiley Periodicals, Inc.

[1]  Fl,et al.  United states. , 2019, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  J. Kurhanewicz,et al.  Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[3]  S. Lipsitz,et al.  Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States , 2012, Cancer.

[4]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[5]  Rajiv Chopra,et al.  The feasibility of endorectal MR elastography for prostate cancer localization , 2011, Magnetic resonance in medicine.

[6]  Thomas Hambrock,et al.  In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.

[7]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[8]  A. Padhani.  Integrating multiparametric prostate MRI into clinical practice , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[9]  Steven P Sourbron,et al.  On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.

[10]  G. Cowin,et al.  16 T Diffusion microimaging of fixed prostate tissue: Preliminary findings , 2011, Magnetic resonance in medicine.

[11]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[12]  Derya Yakar,et al.  Initial Results of 3-Dimensional 1H-Magnetic Resonance Spectroscopic Imaging in the Localization of Prostate Cancer at 3 Tesla: Should We Use an Endorectal Coil? , 2011, Investigative radiology.

[13]  H. Huisman,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[14]  François Cornud,et al.  Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.

[15]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[16]  Xuna Zhao,et al.  A feasibility study of MR elastography in the diagnosis of prostate cancer at 3.0T , 2011, Acta radiologica.

[17]  F. Beuvon,et al.  Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.

[18]  S. Lipsitz,et al.  Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[20]  Heinz-Peter Schlemmer,et al.  Discriminating Cancer From Noncancer Tissue in the Prostate by 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging: A Prospective Multicenter Validation Study , 2011, Investigative radiology.

[21]  M. Reiser,et al.  MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer. , 2010, European journal of radiology.

[22]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[23]  C. Bartolozzi,et al.  Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D 1H MR spectroscopic imaging: correlation with pathologic findings , 2010, Abdominal Imaging.

[24]  A. Evans,et al.  Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.

[25]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[26]  Piotr Kozlowski,et al.  Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. , 2010, Academic radiology.

[27]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[28]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[29]  D. Beyersdorff,et al.  Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation. , 2010, AJR. American journal of roentgenology.

[30]  D. Dearnaley,et al.  A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.

[31]  A. Prando.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .

[32]  Gary P Liney,et al.  Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.

[33]  L. Turnbull,et al.  Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.

[34]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[35]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[36]  Matthias Taupitz,et al.  Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. , 2009, Radiology.

[37]  Bin Wang,et al.  Diffusion‐weighted imaging of prostate cancer: Correlation between apparent diffusion coefficient values and tumor proliferation , 2009, Journal of magnetic resonance imaging : JMRI.

[38]  S. Haker,et al.  Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. , 2009, Magnetic resonance imaging.

[39]  Gary Liney,et al.  Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.

[40]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[41]  John Kurhanewicz,et al.  Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. , 2009, European urology.

[42]  M. Yaffe,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[43]  J. Geitung,et al.  Prostate magnetic resonance imaging: Multiexponential T2 decay in prostate tissue , 2008, Journal of magnetic resonance imaging : JMRI.

[44]  Yousef Mazaheri,et al.  MR imaging of the prostate in clinical practice , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[45]  K. Touijer,et al.  The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[46]  Peter Boesiger,et al.  Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[47]  John Kurhanewicz,et al.  A clinical comparison of rigid and inflatable endorectal‐coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate , 2008, Journal of magnetic resonance imaging : JMRI.

[48]  T. Sone,et al.  Age‐related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues , 2008, Journal of magnetic resonance imaging : JMRI.

[49]  Jason A Koutcher,et al.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.

[50]  T. Scheenen,et al.  Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. , 2007, Radiology.

[51]  H. Hricak,et al.  Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.

[52]  Tristan Barrett,et al.  Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.

[53]  A. Hemal,et al.  Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut‐off value to predict malignancy of the peripheral zone , 2007, NMR in biomedicine.

[54]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[55]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[56]  Esin Ozturk-Isik,et al.  High‐speed 3T MR spectroscopic imaging of prostate with flyback echo‐planar encoding , 2007, Journal of magnetic resonance imaging : JMRI.

[57]  Olivier Rouvière,et al.  Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.

[58]  R. Lenkinski,et al.  3T MR of the prostate: Reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension , 2007, Magnetic resonance in medicine.

[59]  Peter L Choyke,et al.  Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.

[60]  V. Pansadoro,et al.  Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone , 2007, Abdominal Imaging.

[61]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[62]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[63]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[64]  Stephan E Maier,et al.  Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. , 2006, Magnetic resonance imaging.

[65]  Olivier Rouvière,et al.  Prostate MR imaging at high-field strength: evolution or revolution? , 2006, European Radiology.

[66]  J. Kurhanewicz,et al.  Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.

[67]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[68]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[69]  R. Constable,et al.  Measurement and correction of transmitter and receiver induced nonuniformities in vivo , 2005, Magnetic resonance in medicine.

[70]  P. Carroll,et al.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.

[71]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[72]  H. Hricak,et al.  Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.

[73]  William Wells,et al.  Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.

[74]  John W. Fisher,et al.  A Unified Variational Approach to Denoising and Bias Correction in MR , 2003, IPMI.

[75]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[76]  A. Renshaw,et al.  Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. , 2002, Urology.

[77]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[78]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[79]  Lawrence P. Panych,et al.  Echo planar spectroscopic imaging , 2001 .

[80]  D. Kacher,et al.  Sensitivity profiles from an array of coils for encoding and reconstruction in parallel (SPACE RIP) , 2000, Magnetic resonance in medicine.

[81]  D. Sodickson.  Tailored SMASH image reconstructions for robust in vivo parallel MR imaging , 2000, Magnetic resonance in medicine.

[82]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[83]  P. Boesiger,et al.  SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.

[84]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[85]  A. Elster,et al.  Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. , 1999, Radiology.

[86]  J. García-Segura,et al.  In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. , 1999, Magnetic resonance imaging.

[87]  J. K. Kim,et al.  In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil. , 1998, Magnetic resonance imaging.

[88]  G P Liney,et al.  Comparison of conventional single echo and multi‐echo sequences with a fast spin‐echo sequence for quantitative T2 mapping: Application to the prostate , 1996, Journal of magnetic resonance imaging : JMRI.

[89]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[90]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[91]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[92]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[93]  C W Piccoli,et al.  Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.

[94]  C. S. Poon,et al.  Practical T2 quantitation for clinical applications , 1992, Journal of magnetic resonance imaging : JMRI.

[95]  C. Tempany,et al.  Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. , 1991, Radiology.

[96]  R. Turner,et al.  Echo‐planar imaging of diffusion and perfusion , 1991, Magnetic resonance in medicine.

[97]  L P Panych,et al.  Comparing the FAISE method with conventional dual‐echo sequences , 1991, Journal of magnetic resonance imaging : JMRI.

[98]  R E Lenkinski,et al.  Prostate: MR imaging with an endorectal surface coil. , 1989, Radiology.

[99]  J. Martin,et al.  Inflatable surface coil for MR imaging of the prostate. , 1988, Radiology.

[100]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[101]  R B Jeffrey,et al.  Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.

[102]  S. Maier,et al.  Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer--comparison with single-shot echo planner image. , 2011, Magnetic resonance imaging.

[103]  C. Kim,et al.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.

[104]  Kyung Ah Kim,et al.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.

[105]  H. Hricak,et al.  Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.

[106]  G P Liney,et al.  In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. , 1997, Magnetic resonance imaging.

[107]  Robert V. Mulkern,et al.  Density matrix calculations of AB spectra from multipulse sequences: Quantum mechanics meets In vivo spectroscopy , 1994 .

[108]  G. Barker,et al.  Correction of intensity nonuniformity in MR images of any orientation. , 1993, Magnetic resonance imaging.

[109]  M. Resnick,et al.  Magnetic resonance imaging of the prostate. , 1987, Progress in clinical and biological research.